@article{37cf7d9c69a1459bbc045934698e8f85,
title = "Verteporfin plus ranibizumab for choroidal neovascularization in age-related macular degeneration: twelve-month MONT BLANC study results",
abstract = "To compare the efficacy and safety of same-day verteporfin photodynamic therapy (PDT) and intravitreal ranibizumab combination treatment versus ranibizumab monotherapy in neovascular age-related macular degeneration.",
keywords = "Aged, Aged, 80 and over, Angiogenesis Inhibitors, Antibodies, Monoclonal, Humanized, Choroidal Neovascularization, Combined Modality Therapy, Double-Blind Method, Female, Humans, Incidence, Macular Degeneration, Male, Middle Aged, Photochemotherapy, Photosensitizing Agents, Porphyrins, Prospective Studies, Treatment Outcome, Visual Acuity",
author = "Ursula Schmidt-Erfurth and Paolo Lanzetta and Sebastian Wolf and Christian Simader and Erika Tokaji and Stefan Pilz and Annemarie Weisberger and Michael Larsen and {MONT BLANC Study Group}",
note = "Copyright {\textcopyright} 2012 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.",
year = "2012",
doi = "10.1016/j.ophtha.2012.02.002",
language = "English",
volume = "119",
pages = "992--1000",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "5",
}